KemPharm Reports Q4 and FY 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Kempharm (KMPH) PT Lowered to $8 at Oppenheimer
March 1, 2019 9:30 AM ESTOppenheimer analyst Esther Rajavelu lowered the price target on Kempharm (NASDAQ: KMPH) to $8.00 (from $10.00) while maintaining a Outperform rating.
The analyst commented, "KMPH announced 4Q results and provided an update on the business. Management is focused on KP415/KP484 development, with a... More
